The FDA orders cover three menthol-flavored and three mixed berry-flavored products in 3 nicotine strengths. Read More
Search Results for: marketing denial orders
The applications did not provide sufficient evidence to show comparative health risk data.Read More
The December marketing denial orders were the FDA’s first directed at menthol flavored e-cigarettes. Read More
The FDA said the products did not demonstrate its menthol products provide an added benefit.Read More
The company expects sales of its Bidi Vapor disposable to pick up in the second quarter of 2023. Read More
Morgan Stanley said it expected the rejected products to remain on the U.S. market until a court decision.Read More
The products include the Vuse Vibe Tank Menthol 3.0% and the Vuse Ciro Cartridge Menthol 1.5%.Read More
Litigation
News This Week
PMTA
Regulation
U.S. FDA
Vapor Makers Prevail Over FDA in PMTA Denial Suit
The FDA’s refusal to review marketing plans was error and not harmless (disagreeing with Fifth and DC Circuits).Read More
The court denied the stay mainly because Fontem waited too long to file the emergency motion.Read More
The Fifth Circuit denied the companies' requests Monday for review of the agency’s orders.Read More
